Information  X 
Enter a valid email address

PolareanImagPLCOrdGBP0.00037 (POLX)

Date Time Source Announcement
12 Nov 2019 7:00 am
RNS
New System Delivery and Installation
08 Nov 2019 7:00 am
RNS
Grant of options
07 Nov 2019 7:00 am
RNS
Completion of patient enrolment & PDMR appointment
11 Oct 2019 4:17 pm
RNS
Director dealing
  7:01 am
RNS
Polarean notes statement from Amphion Innovations
09 Oct 2019 7:00 am
RNS
Holding(s) in Company
03 Oct 2019 7:00 am
RNS
Polarean notes statement from Amphion Innovations
25 Sep 2019 7:00 am
RNS
Polarean notes statement from Amphion Innovations
24 Sep 2019 7:00 am
RNS
Half-year Report
10 Sep 2019 5:15 pm
RNS
Polarean notes statement from Amphion Innovations
  7:00 am
RNS
New System Installation
09 Aug 2019 4:14 pm
RNS
Statement on Amphion Innovations
05 Aug 2019 7:00 am
RNS
Phase III Clinical Trials update
31 Jul 2019 10:04 am
RNS
Total Voting Rights
30 Jul 2019 3:18 pm
RNS
Holding(s) in Company
  2:25 pm
RNS
Holding(s) in Company
29 Jul 2019 5:31 pm
RNS
Holding(s) in Company
25 Jul 2019 3:31 pm
RNS
Result of AGM
24 Jul 2019 2:45 pm
RNS
Exercise of Warrants
22 Jul 2019 10:00 am
RNS
Placing to raise �2.1 million
11 Jul 2019 7:00 am
RNS
New System Order
27 Jun 2019 7:00 am
RNS
Final Results
13 Jun 2019 5:02 pm
RNS
Investor Symposium presentations available online
11 Jun 2019 7:00 am
RNS
Phase III Clinical Trials - Update
05 Jun 2019 7:00 am
RNS
New System Order
23 May 2019 3:26 pm
RNS
Grant of Share Options
  7:00 am
RNS
London Investor Symposium
21 May 2019 7:00 am
RNS
3rd tranche of $3m pediatric study grant confirmed
13 May 2019 7:00 am
RNS
Clinical trial update
30 Apr 2019 7:00 am
RNS
Total Voting Rights
29 Apr 2019 7:00 am
RNS
Appointment of Chief Financial Officer
02 Apr 2019 7:00 am
RNS
Exercise of Warrants
01 Apr 2019 7:00 am
RNS
Amphion Innovations - Pledge of Polarean shares
15 Feb 2019 7:00 am
RNS
New System Order
24 Jan 2019 7:00 am
RNS
Appointment of Nominated Adviser and Broker
21 Jan 2019 3:36 pm
RNS
Holding(s) in Company
03 Jan 2019 7:00 am
RNS
Holding(s) in Company
28 Dec 2018 2:52 pm
RNS
Result of General Meeting and Total Voting Rights
11 Dec 2018 7:05 am
RNS
Investment in Polarean & Loan Facility Repayment
  7:00 am
RNS
Conditional Fundraise to raise US$4 million
13 Nov 2018 7:00 am
RNS
Licencing Agreement with Duke University
06 Nov 2018 7:00 am
RNS
Company update
05 Nov 2018 7:00 am
RNS
Nominated Adviser Status
03 Oct 2018 7:00 am
RNS
Delivery of Xenon Polariser
23 Aug 2018 7:00 am
RNS
FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22 Aug 2018 7:00 am
RNS
Half-year Report
27 Jul 2018 7:00 am
RNS
Company update
18 Jul 2018 2:28 pm
RNS
Result of AGM
17 Jul 2018 2:49 pm
RNS
Holding(s) in Company
10 Jul 2018 3:22 pm
RNS
Result of Placing
09 Jul 2018 2:41 pm
RNS
Proposed Placing to raise a minimum of �0.78m
21 Jun 2018 10:12 am
RNS
Holding(s) in Company
19 Jun 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Investor Symposium
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t